0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

Let Them Eat Prozac - The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Paperback, New Ed) Loot Price: R726
Discovery Miles 7 260
Let Them Eat Prozac - The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Paperback, New Ed): David...

Let Them Eat Prozac - The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (Paperback, New Ed)

David Healy

 (sign in to rate)
Loot Price R726 Discovery Miles 7 260 | Repayment Terms: R68 pm x 12*

Bookmark and Share

Expected to ship within 12 - 19 working days

View the Table of Contents. Read the Introduction.

aStirring firsthand account of the SSRI wars. . . . Healy is a distinguished research and practicing psychiatrist, university professor, frequent expert witness, former secretary of the British Association for Psychopharmacology, and author of three books in the field. Instead of shrinking from commercial involvement, he has consulted for, run clinical trials for, and at times even testified for most of the major drug firms. But when he pressed for answers to awkward questions about side effects, he personally felt Big Pharma's power to bring about a closing of ranks against troublemakers. That experience among others has left him well prepared to puncture any illusions about the companies' benevolence or scruples.a
--"New York Review of Books"

"A compelling story about mystery, deception, death, disappointment, vindication, and uncertainty."
--"The American Psychological Association"

"Healy confirms his status as one longtime thorn in the side of big drug companies, recounting how he was initially enthusiastic about SSRIs but eventually grew concerned about their side effects."
--"Psychology Today"

"Physicians should be aware of Let Them Eat Prozac."
--"JAMA"

"Let Them Eat Prozac is a double-pronged exploration, first of the SSRI drugs used to treat depression, and second of the drug industry."
--"Publishers Weekly"

"Ultimately, the book is about science, society and the power and misuse of commercial promotion. . . . His investigation is impressive."
--"Nature"

"This very important book will demonstrate beyond your worst dreams that the commercial needs of Big Pharma are the natural-born enemyof independent scientific research."
--John Le CarrA(c)

"Healy presents technical matters clearly. This book could not be more timely."
--"Foreword"

"Let Them Eat Prozac is an interesting history. It asks some stimulating and challenging questions, which are still in need of better and more constructive answers."
--"Journal of the American Academy of Child Adolescent Psychiatry"

"In a flood of academic publications and talks, David Healy has issued harsh criticisms of both the pharmaceutical industry in general and the nearly $20-billion-dollar-a-year antidepressant industry in particular."
--"Boston Globe"

"Healy does raise some timely issues."
--"Psychiatric Services"

"Dr. Healy's tenacity in fighting for what he believes in is admirable."
--"E-Streams"

"[Healy is] the leading authority on the history of psychopharmacology."
--"Times Literary Supplement"

aAn alarming book. . . . The most disturbing part of the story Healy tells is not merely about the risks of SSRIs but about the efforts of the pharmaceutical industry to make sure those risks were not uncovered.a
--"Dissent"

"In his timely new book, Healy draws on his extensive experience in antidepressant studies and involvement in legal actions against drug manufacturers. . . . Healy has the advantage of access to internal pharmaceutical industry documents and makes a strong case."
--"Library Journal"

"The author is an excellent historian who offers a gripping interpretation of the role of the pharmaco-industrial complex in the introduction of SSRIs. His recommendation for a funded agency that would carefully evaluate the benefits and harms of marketed drugs is a superb idea andmuch needed."
--Jonathan Cole, Harvard Medical School

"Healy exposes the massive fraud and deception in the production and marketing of antidepressant drugs, the selevtive serotonin reuptake inhibitors (SSRIs)."
--"Choice"

Prozac. Paxil. Zoloft. Turn on your television and you are likely to see a commercial for one of the many selective serotonin reuptake inhibitors (SSRIs) on the market. We hear a lot about them, but do we really understand how these drugs work and what risks are involved for anyone who uses them?

Let Them Eat Prozac explores the history of SSRIs--from their early development to their latest marketing campaigns--and the controversies that surround them. Initially, they seemed like wonder drugs for those with mild to moderate depression. When Prozac was released in the late 1980s, David Healy was among the psychiatrists who prescribed it. But he soon observed that some of these patients became agitated and even attempted suicide. Could the new wonder drug actually be making patients worse?

Healy draws on his own research and expertise to demonstrate the potential hazards associated with these drugs. He intersperses case histories with insider accounts of the research leading to the development and approval of SSRIs as a treatment for depression. Let Them Eat Prozac clearly demonstrates that the problems go much deeper than a side-effect of a particular drug. The pharmaceutical industry would like us to believe that SSRIs can safely treat depression, anxiety, and a host of other mental problems. But, as Let Them Eat Prozac reveals, this "cure" may be worse than the disease.

General

Imprint: New York University Press
Country of origin: United States
Release date: October 2006
First published: October 2006
Authors: David Healy
Dimensions: 229 x 152 x 23mm (L x W x T)
Format: Paperback - Trade / Trade
Pages: 351
Edition: New Ed
ISBN-13: 978-0-8147-3697-5
Categories: Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
Books > Medicine > Other branches of medicine > Pharmacology > General
Promotions
LSN: 0-8147-3697-1
Barcode: 9780814736975

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Empire Of Pain - The Secret History of…
Patrick Radden Keefe Paperback R385 R347 Discovery Miles 3 470
Pharmacology In Clinical Practice…
Gustav Schellack Paperback R507 Discovery Miles 5 070
Advanced Nanoformulations - Theranostic…
Md Saquib Hasnain, Amit Kumar Nayak, … Paperback R4,223 Discovery Miles 42 230
Drug Delivery Systems for Metabolic…
Harish Dureja, Narasimha Murthy, … Paperback R4,171 Discovery Miles 41 710
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,773 Discovery Miles 47 730
Tamoxifen Tales - Suggestions for…
V.Craig Jordan Hardcover R2,211 Discovery Miles 22 110
Herbal Bioactive-Based Drug Delivery…
Inderbir Singh Bakshi, Rajni Bala, … Paperback R4,215 Discovery Miles 42 150
Process Systems Engineering for…
Ravendra Singh, Zhihong Yuan Hardcover R5,865 R5,428 Discovery Miles 54 280
Orphan Drugs - Understanding the Rare…
Elizabeth Hernberg-Stahl, Miroslav Reljanović Hardcover R4,474 Discovery Miles 44 740
Patently Innovative - How Pharmaceutical…
R A Bouchard Hardcover R4,301 Discovery Miles 43 010
Pharmacoeconomics
Tom Walley, Alan Haycox, … Paperback R1,299 Discovery Miles 12 990
EU Competition Law and Pharmaceuticals
Wolf Sauter, Marcel Canoy, … Hardcover R3,633 Discovery Miles 36 330

See more

Partners